# Study to Evaluate the Tolerability and Immunogenicity of Nyaditum Resae ® Probiotic Administered to Pediatric Population in Contact With Tuberculosis With or Without Latent Tuberculosis Infection

> **NCT02581579** · NA · COMPLETED · sponsor: **Manresana de Micobacteriologia, SL** · enrollment: 24 (actual)

## Conditions studied

- Tuberculosis

## Interventions

- **DIETARY_SUPPLEMENT:** Nyaditum resae ® 10e5 of heat-killed Mycobacterium manresensis
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02581579
- **Lead sponsor:** Manresana de Micobacteriologia, SL
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-12-09
- **Primary completion:** 2019-03-06
- **Final completion:** 2019-03-06
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2019-12-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02581579

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02581579, "Study to Evaluate the Tolerability and Immunogenicity of Nyaditum Resae ® Probiotic Administered to Pediatric Population in Contact With Tuberculosis With or Without Latent Tuberculosis Infection". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02581579. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*